Abstract Hemoglobin E (HbE; b 26Glu ? Lys) is the most common variant of the b-globin gene in Southeast Asia; it has been suggested that it confers resistance against Plasmodium falciparum malaria. In this study 306 adult patients with P. falciparum malaria (198 mild and 108 cerebral malaria patients) living in northwest Thailand were investigated to examine whether the HbE variant is associated with protection from cerebral malaria. Our results revealed that the sample allele frequency of HbE was not significantly different between mild (7.3%) and cerebral malaria (7.4%) patients. Thus, the HbA/HbE polymorphism would not be a major genetic factor influencing the onset of cerebral malaria in Thailand.
Introduction
Plasmodium falciparum malaria is one of the most serious infectious diseases for humans. Approximately 400 million people are attacked by malaria annually, and about 3 million people succumb to the illness. It has been suggested that hemoglobin disorders confer resistance against malarial infection based on the observation that the geographic distribution of hemoglobin disorders globally and locally overlaps regions where malaria is endemic. Hemoglobin E (HbE; b 26Glu ? Lys), which causes the HbE disease and the HbE trait, is the most common variant of the b-globin gene (HBB; OMIM 141900) in malaria-endemic regions of Southeast Asia.
In Thailand, the overall allele frequency of HbE is approximately 13%, and the frequency reaches 50% in some northeastern parts of the country (Fucharoen et al. 1998) . It has been suggested that the high population frequency of HbE was attained rapidly by positive selection against malarial infection (Ohashi et al. 2004 ). In vitro studies have shown inhibition of growth of P. falciparum in HbE erythrocytes (Chotivanich et al. 2002; Vernes et al. 1986; Yuthavong et al. 1987) . Additionally, malaria patients with the HbE trait were reported to suffer severe complications of malaria less frequently, compared with reference patients (Hutagalung et al. 1999) . Although there are many severe symptoms in malaria, the major cause of death due to malarial infection is cerebral malaria. It is therefore important, from the clinical point of view, to assess whether the HbE variant is associated with protection from cerebral malaria.
Materials and Methods

Subjects
To examine a possible association of HbE with protection from cerebral malaria, we genotyped the HbA/HbE polymorphism for 306 patients with falciparum malaria living in northwest Thailand; 198 had mild malaria and 108 had cerebral malaria. All patients underwent treatment at the Hospital for Tropical Diseases, Faculty of Tropical Medicine, Mahidol University. For all patients, malarial infection by P. falciparum was confirmed by a positive blood smear for the asexual form of P. falciparum. Clinical manifestations of malaria were classified according to the definitions and associated criteria by the World Health Organization. Cerebral malaria was defined as unrousable coma, a positive result in tests for the presence of an asexual form of P. falciparum, and exclusion of other causes of coma. Mild malaria was defined as a positive blood smear, fever without other causes of infection, and no signs indicating severe malaria, as following: high parasitemia ([100,000 parasites/ml), hypoglycemia (glucose level \ 22 nmol/l), severe anemia (hematocrit \ 20% or hemoglobin level \ 7.0 g/dl) or increased serum level of creatinine ([3.0 mg/dl). All individuals were 13 years old or older; mean age was 25.6 years for patients with mild malaria and 28.6 years for cerebral malaria patients. This study was approved by the institutional review board of the Faculty of Tropical Medicine, Mahidol University, and the Research Ethics Committee of the Faculty of Medicine, University of Tokyo. Informed consent was obtained from all patients.
DNA Extraction, Amplification, and Sequencing
Genomic DNA from all the patients was purified from peripheral blood leukocytes using a commercially available kit (QIAamp blood kit; Qiagen, Hilden, Germany). Polymerase chain reaction (PCR) was performed for the HbE variant using a 5 0 primer, HBBex1F 5 0 -AGGAGCAGGGAGGGCAGGA-3 0 , and a 3 0 primer, HBBex1R 5 0 -TCCAAGGGTAGACCACCAGC-3 0 . The amplification condition consisted of an initial denaturation at 96°C for 10 min, followed by 35 cycles of denaturation at 96°C for 30 s, annealing at 60°C for 30 s, and extension at 72°C for 30 s, applied using a thermalcycler (GeneAmp PCR system 9700; Perkin-Elmer Applied Biosystems). PCR products were sequenced for all samples using an automated sequencer (ABI Prism 3100; Perkin-Elmer Applied Biosystems).
Statistical Analysis
The difference in genotype and allele frequencies between mild and cerebral malaria patients was examined by Fisher's exact probability test. Table 1 shows the genotype and allele frequencies of the HbA/HbE polymorphism in mild and cerebral malaria patients. The sample frequencies of HbE in mild and cerebral malaria patients were 7.3 and 7.4%, respectively. Neither sample frequency (genotype or allele) was shown to be significantly different between mild and cerebral malaria patients by Fisher's exact probability test. The present results seem to be inconsistent with a previous study showing that the HbE trait is associated with nonpossession of severe-complication malaria (Hutagalung et al. 1999 ). The present study, however, focused only on cerebral malaria among the severe symptoms, which may partially account for the inconsistency. Although a case-control study needs to be conducted to evaluate the association between the HbE variant and the other severe complications of malaria, we conclude that the HbA/HbE polymorphism is not a major genetic factor influencing the onset of cerebral malaria. 
Results and Discussion
